Novo Nordisk: Leading the fight against diabetes through innovative research

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates in five others. Controlled by majority shareholder Novo Holdings A/S, which holds approximately 28% of its shares and 77% of…